Apex Biotechnology Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Apex Biotechnology Corp

Watchlist Manager

Watchlist

Price: 30.4 TWD 0.83% Market Closed

Market Cap: NT$3B

	Apex Biotechnology Corp TWSE:1733	TW
	Nicolas Correa SA MAD:NEA	ES
D	Deutsche Telekom AG F:DTE	DE
	Volati AB F:VOG	SE
	Deutsche Real Estate AG F:DRE2	DE
B	Burlington Stores Inc SWB:BUI	US
L	L'Oreal SA F:LOR	FR
	Thai Beverage PCL SGX:Y92	TH
	Endo Lighting Corp TSE:6932	JP

Profitability Summary

Apex Biotechnology Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

31%

Sustainable 3Y Average Gross Margin

29%

Gross Margin is Increasing

29% > 31%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

7% > 9%

Healthy Net Margin

10%

Low 3Y Average Net Margin

Net Margin is Increasing

9% > 10%

Exceptional Free Cash Flow Margin

14%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.